BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 25789706)

  • 1. EphB2 Promotes Progression of Cutaneous Squamous Cell Carcinoma.
    Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Toriseva M; Kivisaari A; Ala-Aho R; Kallajoki M; Veräjänkorva E; Honkanen HK; Heljasvaara R; Pihlajaniemi T; Grénman R; Peltonen J; Peltonen S; Kähäri VM
    J Invest Dermatol; 2015 Jul; 135(7):1882-1892. PubMed ID: 25789706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma.
    Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Piipponen M; Kivisaari A; Kallajoki M; Grénman R; Peltonen J; Peltonen S; Quint KD; Bavinck JNB; Kähäri VM
    Oncotarget; 2017 Jul; 8(28):45825-45836. PubMed ID: 28526809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor receptor promotes progression of cutaneous squamous cell carcinoma.
    Khandelwal AR; Kent B; Hillary S; Alam MM; Ma X; Gu X; DiGiovanni J; Nathan CO
    Mol Carcinog; 2019 Oct; 58(10):1715-1725. PubMed ID: 31254372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New perspectives on role of tumor microenvironment in progression of cutaneous squamous cell carcinoma.
    Nissinen L; Farshchian M; Riihilä P; Kähäri VM
    Cell Tissue Res; 2016 Sep; 365(3):691-702. PubMed ID: 27411692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long Noncoding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity.
    Piipponen M; Nissinen L; Farshchian M; Riihilä P; Kivisaari A; Kallajoki M; Peltonen J; Peltonen S; Kähäri VM
    J Invest Dermatol; 2016 Aug; 136(8):1701-1710. PubMed ID: 27049681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement C3a promotes proliferation, migration and stemness in cutaneous squamous cell carcinoma.
    Fan Z; Qin J; Wang D; Geng S
    J Cell Mol Med; 2019 May; 23(5):3097-3107. PubMed ID: 30825266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement Component C3 and Complement Factor B Promote Growth of Cutaneous Squamous Cell Carcinoma.
    Riihilä P; Nissinen L; Farshchian M; Kallajoki M; Kivisaari A; Meri S; Grénman R; Peltonen S; Peltonen J; Pihlajaniemi T; Heljasvaara R; Kähäri VM
    Am J Pathol; 2017 May; 187(5):1186-1197. PubMed ID: 28322200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C1r Upregulates Production of Matrix Metalloproteinase-13 and Promotes Invasion of Cutaneous Squamous Cell Carcinoma.
    Viiklepp K; Nissinen L; Ojalill M; Riihilä P; Kallajoki M; Meri S; Heino J; Kähäri VM
    J Invest Dermatol; 2022 May; 142(5):1478-1488.e9. PubMed ID: 34756877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53-Regulated Long Noncoding RNA PRECSIT Promotes Progression of Cutaneous Squamous Cell Carcinoma via STAT3 Signaling.
    Piipponen M; Nissinen L; Riihilä P; Farshchian M; Kallajoki M; Peltonen J; Peltonen S; Kähäri VM
    Am J Pathol; 2020 Feb; 190(2):503-517. PubMed ID: 31837949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GRIM-19 represses the proliferation and invasion of cutaneous squamous cell carcinoma cells associated with downregulation of STAT3 signaling.
    Wu N; Hui H; Cui L; Yang F
    Biomed Pharmacother; 2017 Nov; 95():1169-1176. PubMed ID: 28926927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yes-Associated Protein Contributes to the Development of Human Cutaneous Squamous Cell Carcinoma via Activation of RAS.
    Jia J; Li C; Luo S; Liu-Smith F; Yang J; Wang X; Wang N; Lai B; Lei T; Wang Q; Xiao S; Shao Y; Zheng Y
    J Invest Dermatol; 2016 Jun; 136(6):1267-1277. PubMed ID: 26902922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibulin-3 Has Anti-Tumorigenic Activities in Cutaneous Squamous Cell Carcinoma.
    Wang X; Zhang Q; Li C; Qu X; Yang P; Jia J; Song L; Fan W; Jing H; Zheng Y
    J Invest Dermatol; 2019 Aug; 139(8):1798-1808.e5. PubMed ID: 30738056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-125b down-regulates matrix metallopeptidase 13 and inhibits cutaneous squamous cell carcinoma cell proliferation, migration, and invasion.
    Xu N; Zhang L; Meisgen F; Harada M; Heilborn J; Homey B; Grandér D; Ståhle M; Sonkoly E; Pivarcsi A
    J Biol Chem; 2012 Aug; 287(35):29899-908. PubMed ID: 22782903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour-cell-derived complement components C1r and C1s promote growth of cutaneous squamous cell carcinoma.
    Riihilä P; Viiklepp K; Nissinen L; Farshchian M; Kallajoki M; Kivisaari A; Meri S; Peltonen J; Peltonen S; Kähäri VM
    Br J Dermatol; 2020 Mar; 182(3):658-670. PubMed ID: 31049937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WW domain-containing E3 ubiquitin protein ligase 1 depletion evokes antitumor effect in cutaneous squamous cell carcinoma by inhibiting signal transducer and activator of transcription 3 signaling pathway.
    Xia Y; Chang X; Lian S; Zhu W
    J Int Med Res; 2018 Jul; 46(7):2898-2912. PubMed ID: 29888632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific knockdown of HOXB7 inhibits cutaneous squamous cell carcinoma cell migration and invasion while inducing apoptosis via the Wnt/β-catenin signaling pathway.
    Gao D; Chen HQ
    Am J Physiol Cell Physiol; 2018 Nov; 315(5):C675-C686. PubMed ID: 30067384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-199a inhibits the ability of proliferation and migration by regulating CD44-Ezrin signaling in cutaneous squamous cell carcinoma cells.
    Wang SH; Zhou JD; He QY; Yin ZQ; Cao K; Luo CQ
    Int J Clin Exp Pathol; 2014; 7(10):7131-41. PubMed ID: 25400809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of LINC00319 indicates a poor prognosis and promotes cell proliferation and invasion in cutaneous squamous cell carcinoma.
    Li F; Liao J; Duan X; He Y; Liao Y
    J Cell Biochem; 2018 Dec; 119(12):10393-10405. PubMed ID: 30145798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement factor I promotes progression of cutaneous squamous cell carcinoma.
    Riihilä P; Nissinen L; Farshchian M; Kivisaari A; Ala-Aho R; Kallajoki M; Grénman R; Meri S; Peltonen S; Peltonen J; Kähäri VM
    J Invest Dermatol; 2015 Feb; 135(2):579-588. PubMed ID: 25184960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effects of ephrin B receptor 2 inhibitors screened by molecular docking on cutaneous squamous cell carcinoma.
    Li Y; Zhang X
    J Dermatolog Treat; 2022 Feb; 33(1):373-379. PubMed ID: 32338086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.